ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 224

Standardized Incidence Ratios and Predictors of Malignancies in 215 Southern Chinese Patients with Inflammatory Myopathies

Chi Chiu Mok1, Chi Hung To1, ML Yip2 and King Yee Ying3, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Division of Rheumatology, Department of Medicine, Kwong Wah Hospital, Kowloon, Hong Kong, 3Department of Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Malignancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Clinical and Therapuetic Aspects of Idiopathic Inflammatory Myopathies

Session Type: Abstract Submissions (ACR)

Background/Purpose:

To examine the standardized incidence ratios (SIRs) and predictive factors for malignancy in a cohort of southern Chinese patients with inflammatory myopathies (IM).

Methods:

Patients with polymyositis (PM), dermatomyositis (DM) or amyotrophic dermatomyositis (ADM) diagnosed between 2000 and 2010 in the three regional hospitals were studied.  Diagnosis was made according to the Peter and Bohan criteria. Demographic data, clinical presentation, time of diagnosis of malignancies since diagnosis and the nature of malignancies were retrieved. Patients with malignancies diagnosed more than 1 year before the onset of IM was excluded. The age- and sex-adjusted standardized incidence ratios (SIRs) of malignancies in comparison to those of the general population obtained from the cancer registry of Hong Kong within the same study period were calculated. Demographic data, types of IM (DM vs ADM vs PM), creatine kinase (CK), presence of concomitant rheumatic diseases, extra-muscular manifestations were analyzed as predictors for malignancy in  Cox regression models.

Results:

215 patients (65% women) with IM were studied (125 DM, 75 PM, 15 ADM) with a mean follow-up of 4.7±4.6 years. The mean age of disease onset was 51.5±16.3 years. Concomitant rheumatic diseases were diagnosed in 39 (18.1%) patients.  52 patients (24.2%) (44 DM, 6 PM, 1 ADM) were diagnosed to have malignancies. 13 (25%) and 14 (26.9%) malignancies, respectively, were identified within the preceding 1 year and at the same time of IM diagnosis. The mean time interval between the diagnoses of IM and malignancies was 1.29±1.56 years. The age- and sex-adjusted SIRs for malignancies for DM and PM were 3.9 [2.8-5.5] and 1.1 [0.5-2.6], respectively. The most frequently associated malignancies were: nasopharyngeal cancer 21 (40%), gastrointestinal cancer 10 (19%), lung cancer 10 (19%), breast cancer 4 (7.6%), cervical cancer 3 (5.7%), and the corresponding age- and sex-adjusted SIRs were 26.8 [16.5-41.5], 1.3[0.7-2.5], 1.8[0.9-3.5], 1.9[0.7-5.2], 8.4[2.6-26.5], respectively. On univariate analysis, the age at IM diagnosis (HR 1.03[1.02-1.05]), male gender (HR 3.88[1.95-7.74]), history of smoking (HR 3.86[1.95-7.65]), the diagnosis of DM (HR 3.37[1.39-8.14]), oropharyngeal muscle involvement (HR 2.55[1.28-5.07]) were associated with malignancies whereas the presence of concomitant rheumatic diseases (HR 0.23[0.05-0.95]), presence of interstitial lung disease (HR 0.37[0.16-0.85]) and use of azathioprine (HR 0.35[0.18-0.68]) were protective.  Cox regression analysis revealed that a history of smoking (HR 2.7[1.12-6.56]), and oropharyngeal muscle involvement (HR 2.65[1.22-5.75]) were independently associated with malignancies.

Conclusion:

DM, but not PM, was associated with an increased risk of malignancies compared to general population. DM patients in southern Chinese were particularly at risk of carcinoma of nasopharynx, lung and cervix.


Disclosure:

C. C. Mok,
None;

C. H. To,
None;

M. Yip,
None;

K. Y. Ying,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/standardized-incidence-ratios-and-predictors-of-malignancies-in-215-southern-chinese-patients-with-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology